Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension
Author(s) -
Jiwang Chen,
Justin R. Sysol,
Sunit Singla,
Shuang Zhao,
Aya Yamamura,
Daniela ValdezJasso,
Taimur Abbasi,
Krystyna M. Shioura,
Sakshi Sahni,
Vamsi Reddy,
Arvind Sridhar,
Hui Gao,
Jaime R. Torres,
Sara M. Camp,
Haiyang Tang,
Shui Qing Ye,
Suzy Comhair,
Raed A. Dweik,
Paul M. Hassoun,
Jason X.J. Yuan,
Joe G. N. Garcia,
Roberto F. Machado
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.024557
Subject(s) - nicotinamide phosphoribosyltransferase , medicine , pulmonary hypertension , pulmonary artery , hypoxia (environmental) , vascular smooth muscle , cancer research , vascular remodelling in the embryo , endocrinology , cardiology , nad+ kinase , pharmacology , biology , smooth muscle , enzyme , biochemistry , chemistry , organic chemistry , oxygen
Pulmonary arterial hypertension is a severe and progressive disease, a hallmark of which is pulmonary vascular remodeling. Nicotinamide phosphoribosyltransferase (NAMPT) is a cytozyme that regulates intracellular nicotinamide adenine dinucleotide levels and cellular redox state, regulates histone deacetylases, promotes cell proliferation, and inhibits apoptosis. We hypothesized that NAMPT promotes pulmonary vascular remodeling and that inhibition of NAMPT could attenuate pulmonary hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom